ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed
Longhao Sun
Matched on OpenAlex author ID A5101200159. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper
Papers 5
- MiR-506 Promotes Antitumor Immune Response in Pancreatic Cancer by Reprogramming Tumor-Associated Macrophages toward an M1 Phenotype. Last author DOI 10.3390/biomedicines11112874↗
- IGFBP2 Drives Regulatory T Cell Differentiation through STAT3/IDO Signaling Pathway in Pancreatic Cancer. Co-author DOI 10.3390/jpm12122005↗
- IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway. Co-author DOI 10.1016/j.canlet.2020.12.008↗
- MIR506 induces autophagy-related cell death in pancreatic cancer cells by targeting the STAT3 pathway. Co-author DOI 10.1080/15548627.2017.1280217↗
- MicroRNA Signaling Pathway Network in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.jgg.2015.07.003↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tiantian Yang · 2 shared papers, 2022–2023 · strength 0.42
- Ya’an Kang · 2 shared papers, 2017–2021 · strength 0.19
- Paper IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcino… DOI 10.1016/j.canlet.2020.12.008↗
- Paper MIR506 induces autophagy-related cell death in pancreatic cancer cells by targeting the STAT3 pathway. DOI 10.1080/15548627.2017.1280217↗
- Jason B. Fleming · 2 shared papers, 2017–2021 · strength 0.19
- Paper IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcino… DOI 10.1016/j.canlet.2020.12.008↗
- Paper MIR506 induces autophagy-related cell death in pancreatic cancer cells by targeting the STAT3 pathway. DOI 10.1080/15548627.2017.1280217↗
- Xiaoyu Liang · 1 shared paper, 2022 · strength 0.19
- Liang Liu · 1 shared paper, 2021 · strength 0.12
- Huamin Wang · 1 shared paper, 2021 · strength 0.12
- Wei Zhang · 1 shared paper, 2021 · strength 0.12
- Boris Pasche · 1 shared paper, 2021 · strength 0.12
- Wei Zhang · 1 shared paper, 2017 · strength 0.07
- Wei Zhang · 1 shared paper, 2015 · strength 0.06
- Paul J. Chiao · 1 shared paper, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.